b-Carotene oxygenase 2 cleaves b-carotene asymmetrically at non-central double bonds of the polyene chain, yielding apocarotenal molecules. The hypothesis tested was that apocarotenoids are able to stimulate transcription by activating retinoic acid receptors (RARs). The effects of long-and short-chain apocarotenals and apocarotenoic acids on the activation of RARa and RARb transfected into monkey kidney fibroblast cells (CV-1) were investigated. We synthesized or purified b-apo-8 0 -carotenoic acid (apo-8 0 -CA), b-apo-14 0 -carotenoic acid (apo-14 0 -CA), b-cyclocitral (BCL), b-cyclogernanic acid (BCA), b-ionone (BI), b-ionylideneacetaldehyde (BIA) b-ionylideneacetic acid (BIAA) and a C13 ketone, b-apo-13carotenone (C13). None of the apocarotenoids tested showed significant transactivation activity for the RARs when compared with all-trans retinoic acid (RA). The results suggest that biological effects of these apocarotenoids are through mechanisms other than activation of RARa and b.
Introduction
Bacteria, algae, fungi and plants have the ability to synthesize carotenoids; however, animals, including humans, do not. Of the more than 600 different carotenoids characterized from natural sources, 1, 2 only 60 are present in the human diet. 3 The prominent carotenoids found in human plasma include b-carotene, a-carotene, lycopene, lutein, zeaxanthin and b-cryptoxanthin. 3 b-Carotene can serve as an important dietary source of vitamin A. It can be cleaved either centrally or at non-central double bonds (eccentrically) (Figure 1 ). When cleaved centrally by b,b-carotene-15,15 0 -oxygenase [EC 1.13.11 .31] (BCO1), b-carotene yields two molecules of retinal. 4 In the eccentric cleavage pathway, b-carotene oxygenase 2 (BCO2), also called b,b-carotene-9 0 ,10 0 -oxygenase, catalyzes the cleavage of b-carotene at non-central double bonds of the polyene chain yielding apocarotenals like b-apo-8 0 -, b-apo-10 0 -and b-apo-12 0 -carotenals, which may be further metabolized to the corresponding acids and alcohols. 5 b-Carotene and some of its derivatives possess vitamin A activity. 6 Besides their functions as a precursor of vitamin A and as antioxidants, carotenoids recently attracted research interest because of the possible ability of carotenoid metabolites to modulate retinoid receptors that are responsible for cell differentiation and some aspects of the immune response. 7, 8 While several studies have shown the possibility of apocarotenoids serving as signaling mediators in the cell, information remains limited. The biological roles and the potential regulation of retinoic acid receptors (RARs) by apocarotenoids are not clear. This research tested the hypothesis that apocarotenoids are able to stimulate transcription by activation of RARs. by preparative TLC. b-Cyclogeranic acid (BCA) was prepared by air oxidation of BCL and crystallization of the product. b-ionylideneacetic acid (BIAA) was synthesized by Wadsworth-Emmons reaction (triethylphosphonoacetate) with BI and saponification and chromatography. b-Ionylideneacetaldehyde (BIA) was prepared from BIAA by reduction of BIAA and chromatography. The C13 ketone was made by Wittig reaction (acetonyltriphenylphosphonium chloride) with BIA and chromatography. Finally, b-apo-14 0 -carotenoic acid (apo-14 0 -CA) was prepared by reaction of triethylphosphonoacetate with retinal (Sigma) and saponification and crystallization. Stock solutions of these compounds were prepared by dissolving in absolute ethanol and stored at 2808C, while serial working dilutions were kept at 2208C. The concentrations of the stock solutions were determined either gravimetrically or by spectrophotometry using known or determined molar extinction coefficients. Figure 2 depicts possible b-carotene metabolites that result from eccentric cleavage and boxed compounds were tested for their abilities to transactivate RARa and RARb.
Cell culture and DNA preparation CV-1 cells (male African green monkey kidney fibroblast cell line, ATCC #CCL-70) were purchased from the American Type Cell Culture Collection (Manassas, VA, USA). Cells were kept at 378C with 5% CO 2 in a basic medium, Dulbecco's modified Eagle's medium (DMEM, Invitrogen, Carlsbad, CA, USA) with 10% fetal bovine serum (FBS), 100 mg/mL sodium pyruvate, 100 mg/mL penicillin-streptomycin sulfate and 0.5 mg/mL Fungizone (Invitrogen). Plasmids carrying the ampicillin-resistance gene and a reporter construct with an RARE-driven firefly luciferase gene (pRARE-Luciferase), a construct with renilla luciferase driven by the thymidine kinase promoter (pRL-tk Renilla), control vector (pSG5), and expression vectors for RARa and RARb (pSG5-RARa or b) were gifts from Dr Dianne Soprano, Temple University, School of Medicine (Philadelphia, PA, USA). Like firefly luciferase, renilla luciferase does not require post-translational modification to be activated. Therefore, the renilla luciferase plasmid was used in conjunction with a reporter vector containing the firefly luciferase gene as the transfection normalizer. The constitutive promoter for renilla luciferase was the herpes simplex virus thymidine kinase (HSV-TK). The promoter for the firefly luciferase, a DR5 retinoic acid response element (DR5 RARE), served as the target of the RAR protein produced from the RAR expression plasmids after DNA transfection.
Glycerol stocks of Escherichia coli containing these plasmids were stored at 2808C. Bacteria were cultured on ampicillin containing LB agar plates or liquid media (50 mg/mL) at 378C. DNA was purified using the Qiagen Qiafilter Midi kit (Qiagen) following the manufacturer's instructions. DNAs were analyzed by agarose gel electrophoresis while DNA concentration was determined by measuring absorbance at 260 nm. Purity was determined by comparing the absorbance at 260 and 280 nm.
Cotransfection/transactivation assays
Transactivation assays were performed with CV-1 cells. Cells at 85-90% confluency in six-well plates were cotransfected with 2 mg/well pRARE-Luciferase, 0.025 mg/well pRL-tk Renilla, 5 mg/well pSG5-RAR and 10 mL/well Lipofectamine 2000 TM (Invitrogen), a cationic lipid-based transfection reagent. Before transfection, medium was changed to serum-free DMEM and cells were transfected with plasmids. After four hours, medium was changed to DMEM containing 10% charcoalstripped FBS, 100 mg/mL sodium pyruvate, 100 mg/mL penicillin-streptomycin sulfate and 0.5 mg/mL Fungizone. After 24 h, cells were treated with all-trans-RA and apocarotenoids at varying concentrations or with 0.25% ethanol as the control. In each experiment six wells were treated with ethanol alone and the results were averaged to determine the background (uninduced) luciferase expression. Each concentration of each compound was tested in triplicate wells. Multiple, independent experiments were conducted for retinoic acid, b-apo-8 0 -carotenoic acid and b-apo-14 0 -carotenoic acid.
Dual luciferase assay
Cells were harvested 50 -52 h post-transfection. Luciferase activities (firefly and renilla) were measured sequentially using the Dual-Luciferase reporter (DLR) Assay System (Promega, Madison, WI, USA) following the manufacturer's instructions. Briefly, cell monolayers were incubated in the presence of Passive Lysis buffer II for 25 min. Lysates were transferred to microcentrifuge tubes and centrifuged at 14,000 rpm at 48C for 30 s. Twenty microliters of the supernatant was transferred to a 96-well microtiter plate for the assay. DLR assays were run on a luminometer (Promega). The substrate, Luciferase Assay Reagent II (LAR II), for firefly luciferase was autoinjected into each well containing lysate. Firefly luciferase activity was immediately measured by the luminometer, and the luminescence emission over 10 s was recorded. Stop & Glo TM Reagent (Promega) containing renilla luciferase substrate was then autoinjected into the same well, simultaneously quenching the firefly luciferase reaction and activating the renilla luciferase reaction. The renilla luciferase activity was quantified immediately over a 10-s period by the luminometer.
Data analysis
Each transfection was performed in triplicate and repeated multiple times. The firefly luciferase activity was normalized to renilla luciferase levels. Fold induction of gene expression was obtained by comparison with the ethanol control group.
Results
All-trans RA transactivated RAR and the promoter of the firefly luciferase reporter in a dose-dependent manner. Fold induction was taken by the comparison of corrected firefly luciferase activity in RA-treated wells at various concentrations with those in the ethanol-treated control wells. The results revealed that the fold induction for RARa increased with increasing all-trans RA concentration (Figure 3 ). The induction of firefly/renilla luciferase by alltrans RA compared with ethanol increased from one-to 3.5-fold for RARa with increasing concentrations of RA (10 211 to 10 25 mol/L). The maximum fold induction was achieved at 10 mmol/L all-trans RA, and the half maximal fold induction was achieved at 10 28 mol/L, which is the physiological concentration of RA in human plasma. Similar results were obtained in experiments using RARb (data not shown).
Transactivation of RARa and RARb
Cells transfected with RARa receptor vector were treated with RA (10 210 -10 25 mol/L), b-apo-8 0 -carotenoic acid (apo-8 0 -CA), apo-14 0 -CA and C13 ketone (1 and 10 mmol/ L), BI, BCL and BIAA (10 mmol/L) for 22-24 h. Luciferase activities were measured by the DLR system mentioned above and were expressed as fold induction in treated cells. Data are shown in Figure 4 . Generally, the transactivation activity of all short-or long-chain apocarotenoic acids was negligible in comparison to all-trans RA, although there was variation among the compounds. The fold inductions by apo-8 0 -CA and apo-14 0 -CA were positively correlated with the compound's concentration, suggesting that apo-8 0 -CA and apo-14 0 -CA may be weak RARa ligands. On average, the fold induction by apo-14 0 -CA was lower than apo-8 0 -CA, which is consistent with the results that more apo-14 0 -CA than apo-8 0 -CA was needed to compete effectively with all-trans RA for binding RARa. 9 To test the transactivation activity of b-carotene metabolites from eccentric cleavage on RARb, CV-1 cells were incubated with the following compounds: apo-8 0 -CA, apo-14 0 CA, BI, BIA, BIAA, BCA, BCL and C13 ketone. All-trans RA served as a positive control for all compounds in testing their transactivation of RARb. Cells transfected with the RARb receptor vector were treated with 10 210 -10 25 mol/L RA, 1 mmol/L and 10 mmol/L apo-8 0 -CA, apo-14 0 -CA and C13 ketone and 10 mmol/L BI, BCL and BIAA for 22 -24 h in multiple experiments. Luciferase activities are reported as above and data are shown in Figure 5 . The fold induction by b-apo-8 0 -CA and b-apo-14 0 -CA compared with all-trans RA was negligible indicating no transactivation of RARb. Short-chain apocarotenoids, BI, BCL, BCA and BIAA did not transactivate RARb at 10 mmol/L. RARb was weakly activated by 1 and 10 mmol/L C13 ketone as well as 10 mmol/L BIA.
Discussion
There are two pathways by which b-carotene can be cleaved at double bonds: central and eccentric. The major pathway, the central cleavage, has been more extensively studied. In comparison, the eccentric cleavage pathway has been the subject of debate. In 2001, a mouse enzyme was identified and characterized that cleaved b-carotene at the At concentrations of 10 26 mol/L, the effects on RARb of RA, apo-8 0 -CA, apo-14 0 -CA and C13 ketone were shown by the bars from left to right, respectively. Luciferase activities were measured by dual-luciferase reporter system and were expressed as fold induction in treated cells (see Materials and methods). Data are expressed as the mean + SD or range from multiple experiments as indicated (n) with three independent observations per experiment. If no 'n' is indicated the experiment was conducted once in triplicate induced DNA damage and the expression of cytochrome P450 (CYP) 1A2 in rats. 11 Cleavage at the C9 0 , C10 0 double bond of b-Carotene produces b-apo-10 0 -carotenal and b-ionone. b-Ionone was found to inhibit cell proliferation and induce apoptosis in human and murine gastric cancer cell lines, as well as in the mammary gland of rats. 12, 13 The exact pathway for b-ionone-mediated effects on cell proliferation and apoptosis has not been established and no study has related such cellular responses to the activation of RARs. BIA and BIAA, the short-chain products resulting from the cleavage of the C11 0 , C12 0 double bond of b-carotene, reduced rhodopsin regeneration from their apoproteins 14 and inhibited the development of bean embryonic axes, 15 respectively. Cleavage of b-carotene at the C13 0 , C14 0 double bond produces b-apo-14 0 -carotenal and C13 ketone. b-apo-14 0 -carotenoids have been shown to inhibit RXRa, PPARa, g and d, LXRa and LXRb activation. 8 This research tested both short-chain apocarotenoids (BI, BCL, BIA, BIAA, C13 ketone and BCA) and long-chain apocarotenoids (b-apo-14-CA' and b-apo-8-CA) that were readily available or that we were able to synthesize. b-Apo-10 0 -and b-apo-12 0 -carotenoids need to be tested for potential biological functions in future experiments.
Although several studies have examined apocarotenoid biological activity, information remains limited with respect to the basic mechanisms of their biological function. Whether they bind to nuclear receptors or are further metabolized to retinoic acid has not been clarified. We approached this research with the idea of investigating potential biological functions the apocarotenoids could serve within the cell. The possible regulation of RAR by apocarotenoids has not been previously described. Since apocarotenoids with certain chain lengths share some structural similarities with retinoic acid, we hypothesized that these eccentric cleavage products are able to activate RAR.
We investigated the effect of both long-and short-chain apocarotenals or apocarotenoic acids and all-trans RA on the activation of RARa and b transfected into monkey kidney fibroblast cells (CV-1 cells). The transactivation between RAR and the RARE promoter of firefly luciferase DNA led to the transcription of firefly luciferase DNA and eventually firefly luciferase protein production. The constant ratio among Renilla luciferase, firefly luciferase and RAR DNA cotransfected into cells at the same time made sure that the transfection efficiency and cell density were well controlled. Ethanol and all-trans retinoic acid acted as negative and positive controls, respectively, for the synthetic apocarotenals and apocarotenoic acids. The dual luciferase system represented a useful model for testing the transactivation activity of apocarotenoids on RARs. This kind of assay using CV-1 cells was first developed by Chambon and colleagues 16 to assess the potency of retinoids in RAR-mediated transcriptional activation. CV-1 cells have low endogenous expression of RARS and have been widely used as a model transfection system to study transcriptional activation by RARs (see reference 17 and references therein).
Our study showed that long-chain apocarotenoic acids did not transactivate RARa and b. In comparison, previous studies have demonstrated that they had weak biological activity on cell growth inhibition and cell differentiation.
b-Apo-14 0 -CA was able to stimulate the differentiation of human acute promyelocytic leukemia cells and inhibit the growth of normal human bronchial epithelial cells and breast cancer cells. b-Apo-12 0 -CA inhibited the growth of HL-60 cells. 18 In addition, previous studies indicated that longchain apocarotenoic acids were not able to activate RARs. Tibaduiza et al. 19 showed that long-chain b-apocarotenoic acids (8 0 , 10 0 , 12 0 and 14 0 ) were not able to effectively compete with all-trans RA binding with RARs. Therefore, long-chain apocarotenoic acids possibly carry out their biological activity independent of RAR transcriptional activation. In fact, longchain apocarotenoids were demonstrated to activate other transcription systems, such as the AP-1 transcription system and PPAR/RXR nuclear receptors. 8 Future studies investigating the transactivation on AP-1, PPAR/RXR or other nuclear receptors might help reveal the mechanism of the biological activities of long-chain apocarotenoic acids.
Short-chain apocarotenoids were also not able to transactivate RARa and b. Some short-chain apocarotenoids have biological activities, such as inhibiting cell growth and proliferation of cancer cells, inducing apoptosis in mammary gland of rat and reducing rhodopsin regeneration. 14 Our experiments on the transactivation activity of b-carotene derivatives suggest that the biological effects of these apocarotenoids are through mechanisms other than transactivation of RARa and b. These might include the activation of other ligand-dependent transcription factors.
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